Dr. Edith Suzarte has 20 years of experience developing vaccine candidates against infectious diseases such as cholera, malaria, pertussis, dengue, Zika, and SARS-CoV-2 first at the Center for Scientific Research and later at the Center for Genetic Engineering and Biotechnology, Havana, Cuba. Her expertise encompasses molecular biology, protein purification, immunology, virology, and immunochemistry. From 2019 to the present she lead the Dengue Vaccine Project, where her efforts are focused on developing a safe vaccine candidate free from the risk of immunoamplification
Dr. Edith Suzarte has 20 years of experience developing vaccine candidates against infectious diseases such as cholera, malaria, pertussis, dengue, Zika, and SARS-CoV-2 first at the Center for Scientific Research and later at the Center for Genetic Engineering and Biotechnology, Havana, Cuba. Her expertise encompasses molecular biology, protein purification, immunology, virology, and immunochemistry. From 2019 to the present she lead the Dengue Vaccine Project, where her efforts are focused on developing a safe vaccine candidate free from the risk of immunoamplification